Cardiovascular Critical Care I
2022 ACC/AHA guideline for the management of
patients with ST-elevation myocardial infarction: a
report of the American College of Cardiology/American
Heart Association Joint Committee on Clinical Practice
Guidelines.
Circulation.
2022;145(18).
https://doi.
org/10.1161/CIR.0000000000001063
Acharya MN, Som R, Tsui S. What is the optimum anti-
biotic prophylaxis in patients undergoing implantation
of a left ventricular assist device? Interact Cardiovasc
Thorac Surg. 2012;14(2):209-214. https://doi.org/10.1093/
icvts/ivr054
Al-Khatib SM, Stevenson WG, Ackerman MJ, et al.
2017 AHA/ACC/HRS guideline for management of
patients with ventricular arrhythmias and the preven-
tion of sudden cardiac death: executive summary: a
report of the American College of Cardiology/American
Heart Association Task Force on Clinical Practice
Guidelines and the Heart Rhythm Society. J Am Coll
Cardiol. 2018;72(14):1677-1749. https://doi.org/10.1016/j.
jacc.2017.10.053
Amsterdam EA, Wenger NK, Brindis RG, et al. 2014
AHA/ACC guideline for the management of patients
with non-ST-elevation acute coronary syndromes: a
report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines.
Circulation.
2014;130(25):e344-e426.
https://doi.
org/10.1161/cir.0000000000000134
Bangash MN, Kong ML, Pearse RM. Use of inotro-
pes and vasopressor agents in critically ill patients.
Br J Pharmacol. 2012;165(7):2015-2033. https://doi.
org/10.1111/j.1476-5381.2011.01588.x
Baran DA, Grines CL, Bailey S, et al. SCAI clinical
expert consensus statement on the classification of car-
diogenic shock: This document was endorsed by the
American College of Cardiology (ACC), the American
Heart Association (AHA), the Society of Critical Care
Medicine (SCCM), and the Society of Thoracic Surgeons
(STS) in April 2019. Catheter Cardiovasc Interv.
2019;94(1):29-37. https://doi.org/10.1002/ccd.28329
Baron TH, Kamath PS, McBane RD. Management of
antithrombotic therapy in patients undergoing invasive
procedures. N Engl J Med. 2013;368(22):2113-2124.
https://doi.org/10.1056/nejmra1206531
Beavers CJ, DiDomenico RJ, Dunn SP, et al. Optimizing
anticoagulation for patients receiving Impella support.
2021;41(11):932-942.
https://doi.
org/10.1002/phar.2629
Bergen K, Sridhara S, Cavarocchi N, Silvestry S, Ventura
D. Analysis of bicarbonate-based purge solution in patients
with cardiogenic shock supported via Impella ventricular
https://doi.org/10.1177/10600280221124156
Brilakis ES, Banerjee S. Patient with coronary stents
1452. https://doi.org/10.1001/jama.2013.279123
Brilakis ES, Banerjee S. Perioperative manage-
ment of drug-eluting stents: the Achilles heel of
bridging. Catheter Cardiovasc Interv. 2013;82(7):1113-
1114. https://doi.org/10.1002/ccd.25243
Brilakis ES, Patel VG, Banerjee S. Medical man-
agement after coronary stent implantation: a review.
2013;310(2):189-198.
https://doi.org/10.1001/
jama.2013.7086
Brouwer J, Nijenhuis VJ, Delewi R, et al. Aspirin with
or without clopidogrel after transcatheter aortic-valve
implantation. N Engl J Med. 2020;383(15):1447-1457.
https://doi.org/10.1056/nejmoa2017815
Cavallari LH, Lee CR, Beitelshees AL, et al; IGNITE
Network. Multisite investigation of outcomes with
implementation of CYP2C19 genotype-guided antiplate-
let therapy after percutaneous coronary intervention.
JACC Cardiovasc Interv. 2018;11(2):181-191. https://doi.
org/10.1016/j.jcin.2017.07.022
Claassens DMF, Vos GJA, Bergmeijer TO, et al. A geno-
type-guided strategy for oral P2Y12 inhibitors in primary
PCI. N Engl J Med. 2019;381(17):1621-1631. https://doi.
org/10.1056/nejmoa1907096
Collet JP, Thiele H, Barbato E, et al. 2020 ESC guide-
lines for the management of acute coronary syndromes
in patients presenting without persistent ST-segment ele-
vation. Eur Heart J. 2021;42(14):1289-1367. https://doi.
org/10.1093/eurheartj/ehaa575
Cooper HA, Panza JA. Cardiogenic shock. Cardiol
Clin. 2013;31(4):567-580, viii. https://doi.org/10.1016/j.
ccl.2013.07.009